Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

Background. Early diagnosis and treatment are crucial in invasive fungal diseases (IFD). Serum (1-3)-β-d-glucan (BG) is believed to be an early IFD marker, but its diagnostic performance has been ambiguous, with insufficient data regarding sensitivity at the time of IFD diagnosis (TOD) and according...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Forum Infect Dis
Glavni autori: Angebault, Cécile, Lanternier, Fanny, Dalle, Frédéric, Schrimpf, Cécile, Roupie, Anne-Laure, Dupuis, Aurélie, Agathine, Aurélie, Scemla, Anne, Paubelle, Etienne, Caillot, Denis, Neven, Bénédicte, Frange, Pierre, Suarez, Felipe, d'Enfert, Christophe, Lortholary, Olivier, Bougnoux, Marie-Elisabeth
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Major Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942764/
https://ncbi.nlm.nih.gov/pubmed/27419189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw128
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items